Literature DB >> 30355486

Human Huntington's Disease iPSC-Derived Cortical Neurons Display Altered Transcriptomics, Morphology, and Maturation.

Shagun R Mehta1, Colton M Tom1, Yizhou Wang2, Catherine Bresee3, David Rushton1, Pranav P Mathkar1, Jie Tang2, Virginia B Mattis4.   

Abstract

Huntington's disease (HD) is a neurodegenerative disease caused by an expanded CAG repeat in the Huntingtin (HTT) gene. Induced pluripotent stem cell (iPSC) models of HD provide an opportunity to study the mechanisms underlying disease pathology in disease-relevant patient tissues. Murine studies have demonstrated that HTT is intricately involved in corticogenesis. However, the effect of mutant Hungtintin (mtHTT) in human corticogenesis has not yet been thoroughly explored. This examination is critical, due to inherent differences in cortical development and timing between humans and mice. We therefore differentiated HD and non-diseased iPSCs into functional cortical neurons. While HD patient iPSCs can successfully differentiate toward a cortical fate in culture, the resulting neurons display altered transcriptomics, morphological and functional phenotypes indicative of altered corticogenesis in HD.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Huntingtin; Huntington’s disease; cerebral cortex; corticogenesis; differentiation; iPSC

Mesh:

Year:  2018        PMID: 30355486     DOI: 10.1016/j.celrep.2018.09.076

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  35 in total

1.  Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

Authors:  Joel D Federspiel; Todd M Greco; Krystal K Lum; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2019-04-30       Impact factor: 5.911

2.  The Evolution of Stem Cells, Disease Modeling, and Drug Discovery for Neurological Disorders.

Authors:  Cameron Pernia; Brian T D Tobe; Ryan O'Donnell; Evan Y Snyder
Journal:  Stem Cells Dev       Date:  2020-05-06       Impact factor: 3.272

3.  Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease.

Authors:  Joshua D Crapser; Joseph Ochaba; Neelakshi Soni; Jack C Reidling; Leslie M Thompson; Kim N Green
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

Review 4.  Phenotyping Neurodegeneration in Human iPSCs.

Authors:  Jonathan Li; Ernest Fraenkel
Journal:  Annu Rev Biomed Data Sci       Date:  2021-04-23

Review 5.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.

Authors:  Swati Naphade; Kizito-Tshitoko Tshilenge; Lisa M Ellerby
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 6.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 7.  Advances in development and application of human organoids.

Authors:  Abhijith Shankaran; Keshava Prasad; Sima Chaudhari; Angela Brand; Kapaettu Satyamoorthy
Journal:  3 Biotech       Date:  2021-05-08       Impact factor: 2.406

8.  RNA-seq analysis reveals significant transcriptome changes in huntingtin-null human neuroblastoma cells.

Authors:  Johanna Bensalel; Hongyuan Xu; Michael L Lu; Enrico Capobianco; Jianning Wei
Journal:  BMC Med Genomics       Date:  2021-07-02       Impact factor: 3.063

Review 9.  Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data.

Authors:  Karolina Świtońska-Kurkowska; Bart Krist; Joanna Delimata; Maciej Figiel
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 10.  Taming the Huntington's Disease Proteome: What Have We Learned?

Authors:  Connor Seeley; Kimberly B Kegel-Gleason
Journal:  J Huntingtons Dis       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.